Technologies
ImVisioN’s concept for immunotherapy is based on the induction of a highly efficient immune response via an increased presentation of allergen molecules to the immune system. Traditional allergen specific immunotherapy can cure severe allergies. However, this approach involves multiple physician consultations with 50 to 80 injections over a prolonged period and the risk of severe reactions to the treatment. It is therefore an expensive treatment regimen and suffers from poor patient compliance.
In contrast, the ImVisioN approach to allergen immunotherapy involves only three injections over a shorter time period and promises to be both safer and more effective than the traditional therapy. ImVisioN accomplishes this through two proprietary technologies that deliver a new generation of allergy treatments:
- Intralymphatic immunotherapy (ILIT ™)
- Modular Antigen Transportation ™ (MAT ™)